Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease?
J M Lee, C A O'Morain
Department of
Gastroenterology, Meath/Adelaide hospitals, Trinity
college, Dublin, Ireland
Correspondence to: Professor Colm A O'Morain, Department of Gastroenterology, Meath Hospital, Heytesbury Street, Dublin 8, Ireland.
| The first 150 words of the full text of this article appear below. |
| |
Summary |
|---|
Available evidence would suggest that Helicobacter
pylori infection does not contribute to the pathogenesis of
gastro-oesophageal reflux disease. The prevalence of H
pylori infection in patients with reflux disease is no greater
than that in control populations. There are some data suggesting that
the organism has a protective role: patients with duodenal ulcers
develop reflux disease after H pylori eradication, whereas
in patients with oesophageal reflux those with H pylori
infection have less severe reflux changes. There is also evidence
indicating that the presence of H pylori augments the
anti-secretory properties of both the H2 receptor antagonists and proton pump inhibitors (PPIs), suggesting that eradication therapy may not be beneficial. However, the considerable recent interest in the association between H pylori and
reflux disease has largely been generated by studies outlining the
interactions between H pylori infection and acid
suppression in the long term. In H pylori positive
patients, therapy
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
